O USO DA INTELIGÊNCIA ARTIFICIAL NO MANEJO DA HIPERTENSÃO ARTERIAL
O USO DA INTELIGÊNCIA ARTIFICIAL NO MANEJO DA HIPERTENSÃO ARTERIAL
-
DOI: https://doi.org/10.22533/at.ed.31224090912
-
Palavras-chave: "Inteligência Artificial"; "Hipertensão Arterial"
-
Keywords: "Artificial Intelligence";"Arterial Hypertension"
-
Abstract: Hypertension (HT) is a chronic condition characterized by elevated blood pressure levels in the arteries, affecting approximately 1.4 billion people globally and 24% of the adult population in Brazil. It is a significant risk factor for severe conditions such as myocardial infarction, stroke, sudden death, vision loss, and renal failure. HT is usually diagnosed based on daily blood pressure measurements, with values above 140/90 mmHg classified as Stage I HT. However, measurement inaccuracies and the lack of noticeable symptoms can delay diagnosis. Recently, artificial intelligence (AI) has emerged as a promising ally in hypertension management. AI can simulate human reasoning to identify risks by considering a range of factors, including genetics, metabolism, environment, and lifestyle, allowing for more personalized and effective treatment. Additionally, AI is introducing new, non-invasive methods for measuring blood pressure, helping to overcome issues like white coat hypertension and masked hypertension, and improving monitoring accuracy and treatment adjustments. Machine learning (ML) and deep learning (DL) technologies are revolutionizing HT diagnosis and treatment. ML performs predictive analyses by examining relationships between health data variables, while DL uses neural networks to recognize patterns in cardiovascular images and tests. These technologies enable earlier detection and more effective management of HT, as well as improving home monitoring and telemedicine. However, the implementation of AI in hypertension management faces challenges such as the need for high-quality data, privacy concerns, and the development of robust research models. Ethical and regulatory issues regarding data collection and analysis also need to be addressed. Further research is necessary to validate these models and overcome limitations in blood pressure measurement and data interpretation. In summary, AI has the potential to transform hypertension treatment with more precise and personalized approaches. However, its implementation must be ethical and patient-centered, addressing challenges and ensuring reliability through ongoing research and collaboration between medical professionals and AI experts.
- Ana Carolina Tanzi Bernardes
- Breno de Amaral Gandini
- Eduarda Gonçalves Godinho
- Thaís Gabrielly Gomes
- Maria Luiza Garcia Santos
- Maria Eduarda Durante Mazucato
- Laura Turini Baraldi
- Mariana Aires Marangoni
- Arielle Servato Rossi
- Larissa Soares Leite